Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 636 of 1,261

  1. EP 3157548

    THERAPIE MIT EINEM FAKTOR-XII-INHIBITOR BEI EINER NEUROTRAUMATISCHEN STÖRUNG

    CSL BEHRING GMBH [DE] · Granted Apr 26, 2017 · Expires Apr 21, 2037

    granted

  2. US 9629805

    Stabilization of moisture-sensitive drugs

    AMNEAL PHARMACEUTICALS LLC · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  3. US 9629877

    Human application of engineered chimeric antigen receptor (CAR) T-cells

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  4. US 9631192

    Auto-recognizing therapeutic RNA/DNA chimeric nanoparticles (NP)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  5. US 9629932

    Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  6. US 9629914

    Heparosan-based biomaterials and coatings and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  7. US 9631041

    PH-sensitive compositions for delivery of beta lapachone and methods of use

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  8. US 9630931

    Pharmaceutically active pyrazine derivatives

    SENTINEL ONCOLOGY LIMITED · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  9. US 9629843

    MTOR modulators and uses thereof

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  10. US 9631186

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Biosciences, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  11. US 9631193

    Compositions and methods for inhibiting expression of the ALAS1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  12. US 9632074

    Compositions and methods for treating cancer and diseases and conditions responsive to cell growth inhibition

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  13. US 9631187

    Methods and compositions for gene correction

    Sangamo Biosciences, Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  14. US 9631188

    Human cystathionine β-synthase variants and methods of production thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  15. US 9631092

    Degradable thiol-ene polymers

    The Regents of the University of Colorado · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  16. US 9631001

    Peptide antagonists of the vasopressin-2 receptor

    Universität Regensburg · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  17. US 9630999

    Use of Salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

    Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  18. US 9630990

    Inhibition of pulmonary fibrosis with nutlin-3A and peptides

    The Board of Regents of the University of Texas System · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  19. US 9630960

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  20. US 9630932

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Aurigene Discovery Technologies Limited · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  21. US 9630924

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  22. US 9630929

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  23. US 9630956

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

  24. US 9630914

    Multitarget FAAH and COX inhibitors and therapeutical uses thereof

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.